Publication:
Patient-reported questionnaires to identify adverse drug reactions: A systematic review

dc.contributor.authorRenly Limen_US
dc.contributor.authorLisa Kalisch Elletten_US
dc.contributor.authorElizabeth E. Rougheaden_US
dc.contributor.authorPhaik Yeong Cheahen_US
dc.contributor.authorNashwa Masnoonen_US
dc.contributor.otherFaculty of Tropical Medicine, Mahidol Universityen_US
dc.contributor.otherUniversity of South Australiaen_US
dc.contributor.otherThe University of Sydneyen_US
dc.contributor.otherNuffield Department of Medicineen_US
dc.contributor.otherRoyal North Shore Hospitalen_US
dc.contributor.otherUniversity of Oxford Medical Sciences Divisionen_US
dc.date.accessioned2022-08-04T08:39:29Z
dc.date.available2022-08-04T08:39:29Z
dc.date.issued2021-11-01en_US
dc.description.abstractBackground: This systematic review aims to summarise available patient-reported questionnaires to detect adverse drug reactions (ADRs) that can be utilised by healthcare professionals in clinical practice and to summarise the psychometric properties (validity, reliability, and responsiveness) of the questionnaires. Methods: A systematic literature search was conducted using Medline, Pubmed, Embase, and Emcare databases to screen for articles published between January 2000 and July 2020. Data items regarding validity, reliability, and responsiveness were extracted independently by two authors. The methodological quality was assessed using the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) checklist. Results: A total of 1563 unique article titles were identified after removing duplicates. Following shortlisting of relevant articles, 19 patient-reported ADR questionnaires were identified. Questionnaires most commonly focused on mental health medications (42.1%, n = 8), followed by general questionnaires applicable to any medication (21.1%, n = 4). Many questionnaires did not report assessing the validity and reliability of the measurement tool. For example, only 11 questionnaires (58%) mentioned assessing content validity, in addition to criterion or construct testing. Conclusion: This systematic review summarised the available patient-reported questionnaires that can be used in research and clinical practice to identify ADRs. Results of this systematic review highlight the need for more robust validity and reliability testing when developing patient-reported ADR questionnaires.en_US
dc.identifier.citationInternational Journal of Environmental Research and Public Health. Vol.18, No.22 (2021)en_US
dc.identifier.doi10.3390/ijerph182211877en_US
dc.identifier.issn16604601en_US
dc.identifier.issn16617827en_US
dc.identifier.other2-s2.0-85118923599en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/77000
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118923599&origin=inwarden_US
dc.subjectEnvironmental Scienceen_US
dc.subjectMedicineen_US
dc.titlePatient-reported questionnaires to identify adverse drug reactions: A systematic reviewen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118923599&origin=inwarden_US

Files

Collections